0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Veterinary Vaccines - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-19O6094
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global and United States Veterinary Vaccines Market Report Forecast 2022 2028
BUY CHAPTERS

Veterinary Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-19O6094
Report
December 2023
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Vaccines - Market Size

The global Veterinary Vaccines market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029.

Veterinary Vaccines -  Market

Veterinary Vaccines - Market

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The market is mainly driven by the significant applications of Veterinary Vaccines in various end use industries. The expanding demands from the Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute and Retail Pharmacy, are propelling Veterinary Vaccines market. Inactivated Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live Attenuated Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 106%.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Veterinary Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Vaccines covered in this report include Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc.
The global Veterinary Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac

Scope of Veterinary Vaccines - Market Report

Report Metric Details
Report Name Veterinary Vaccines - Market
Forecasted market size in 2029 US$ 12680 million
CAGR 6.1%
Forecasted years 2023 - 2029
Global Veterinary Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Vaccines market, Segment by Type:
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
  • Others
Global Veterinary Vaccines market, by Application
  • Veterinary Clinic
  • Veterinary Hospital
  • Veterinary Research Institute
  • Retail Pharmacy
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Veterinary Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Veterinary Vaccines - Market size in 2029?

Ans: The Veterinary Vaccines - Market size in 2029 will be US$ 12680 million.

What is the Veterinary Vaccines - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years.

What are the Application segmentation covered in the Veterinary Vaccines - Market report?

Ans: The Applications covered in the Veterinary Vaccines - Market report are Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, Retail Pharmacy, Others

What are the Type segmentation covered in the Veterinary Vaccines - Market report?

Ans: The Types covered in the Veterinary Vaccines - Market report are Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Others

1 Market Overview of Veterinary Vaccines
1.1 Veterinary Vaccines Market Overview
1.1.1 Veterinary Vaccines Product Scope
1.1.2 Veterinary Vaccines Market Status and Outlook
1.2 Global Veterinary Vaccines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Vaccines Market Size by Region (2018-2029)
1.4 Global Veterinary Vaccines Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Vaccines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Vaccines Market Size (2018-2029)
1.6.1 North America Veterinary Vaccines Market Size (2018-2029)
1.6.2 Europe Veterinary Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Vaccines Market Size (2018-2029)
1.6.4 Latin America Veterinary Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Vaccines Market Size (2018-2029)
2 Veterinary Vaccines Market by Type
2.1 Introduction
2.1.1 Inactivated Vaccines
2.1.2 Live Attenuated Vaccines
2.1.3 Conjugate Vaccines
2.1.4 Toxoid Vaccines
2.1.5 Recombinant Vaccines
2.1.6 DNA Vaccines
2.1.7 Others
2.2 Global Veterinary Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Vaccines Historic Market Size by Type (2018-2023)
2.2.2 Global Veterinary Vaccines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Veterinary Vaccines Revenue Breakdown by Type (2018-2029)
3 Veterinary Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Clinic
3.1.2 Veterinary Hospital
3.1.3 Veterinary Research Institute
3.1.4 Retail Pharmacy
3.1.5 Others
3.2 Global Veterinary Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Vaccines Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Vaccines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Vaccines Revenue Breakdown by Application (2018-2029)
4 Veterinary Vaccines Competition Analysis by Players
4.1 Global Veterinary Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2022)
4.3 Date of Key Players Enter into Veterinary Vaccines Market
4.4 Global Top Players Veterinary Vaccines Headquarters and Area Served
4.5 Key Players Veterinary Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Elanco
5.1.1 Elanco Profile
5.1.2 Elanco Main Business
5.1.3 Elanco Veterinary Vaccines Products, Services and Solutions
5.1.4 Elanco Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.1.5 Elanco Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Veterinary Vaccines Products, Services and Solutions
5.2.4 Merck Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Merial
5.3.1 Merial Profile
5.3.2 Merial Main Business
5.3.3 Merial Veterinary Vaccines Products, Services and Solutions
5.3.4 Merial Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.3.5 Zoetis Recent Developments
5.4 Zoetis
5.4.1 Zoetis Profile
5.4.2 Zoetis Main Business
5.4.3 Zoetis Veterinary Vaccines Products, Services and Solutions
5.4.4 Zoetis Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.4.5 Zoetis Recent Developments
5.5 Advaxis
5.5.1 Advaxis Profile
5.5.2 Advaxis Main Business
5.5.3 Advaxis Veterinary Vaccines Products, Services and Solutions
5.5.4 Advaxis Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.5.5 Advaxis Recent Developments
5.6 AmpliPhi Biosciences
5.6.1 AmpliPhi Biosciences Profile
5.6.2 AmpliPhi Biosciences Main Business
5.6.3 AmpliPhi Biosciences Veterinary Vaccines Products, Services and Solutions
5.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.6.5 AmpliPhi Biosciences Recent Developments
5.7 Aratana Therapeutics
5.7.1 Aratana Therapeutics Profile
5.7.2 Aratana Therapeutics Main Business
5.7.3 Aratana Therapeutics Veterinary Vaccines Products, Services and Solutions
5.7.4 Aratana Therapeutics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.7.5 Aratana Therapeutics Recent Developments
5.8 ARKO Labs
5.8.1 ARKO Labs Profile
5.8.2 ARKO Labs Main Business
5.8.3 ARKO Labs Veterinary Vaccines Products, Services and Solutions
5.8.4 ARKO Labs Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.8.5 ARKO Labs Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Veterinary Vaccines Products, Services and Solutions
5.9.4 Bayer Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 CanFel Therapeutics
5.10.1 CanFel Therapeutics Profile
5.10.2 CanFel Therapeutics Main Business
5.10.3 CanFel Therapeutics Veterinary Vaccines Products, Services and Solutions
5.10.4 CanFel Therapeutics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.10.5 CanFel Therapeutics Recent Developments
5.11 Ceva Animal Health
5.11.1 Ceva Animal Health Profile
5.11.2 Ceva Animal Health Main Business
5.11.3 Ceva Animal Health Veterinary Vaccines Products, Services and Solutions
5.11.4 Ceva Animal Health Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.11.5 Ceva Animal Health Recent Developments
5.12 Colorado Serum
5.12.1 Colorado Serum Profile
5.12.2 Colorado Serum Main Business
5.12.3 Colorado Serum Veterinary Vaccines Products, Services and Solutions
5.12.4 Colorado Serum Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.12.5 Colorado Serum Recent Developments
5.13 Epitopix
5.13.1 Epitopix Profile
5.13.2 Epitopix Main Business
5.13.3 Epitopix Veterinary Vaccines Products, Services and Solutions
5.13.4 Epitopix Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.13.5 Epitopix Recent Developments
5.14 Genus
5.14.1 Genus Profile
5.14.2 Genus Main Business
5.14.3 Genus Veterinary Vaccines Products, Services and Solutions
5.14.4 Genus Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.14.5 Genus Recent Developments
5.15 Hygieia Biological Laboratories
5.15.1 Hygieia Biological Laboratories Profile
5.15.2 Hygieia Biological Laboratories Main Business
5.15.3 Hygieia Biological Laboratories Veterinary Vaccines Products, Services and Solutions
5.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.15.5 Hygieia Biological Laboratories Recent Developments
5.16 ImmuCell
5.16.1 ImmuCell Profile
5.16.2 ImmuCell Main Business
5.16.3 ImmuCell Veterinary Vaccines Products, Services and Solutions
5.16.4 ImmuCell Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.16.5 ImmuCell Recent Developments
5.17 Nexvet
5.17.1 Nexvet Profile
5.17.2 Nexvet Main Business
5.17.3 Nexvet Veterinary Vaccines Products, Services and Solutions
5.17.4 Nexvet Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.17.5 Nexvet Recent Developments
5.18 Nuovo Biologics
5.18.1 Nuovo Biologics Profile
5.18.2 Nuovo Biologics Main Business
5.18.3 Nuovo Biologics Veterinary Vaccines Products, Services and Solutions
5.18.4 Nuovo Biologics Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.18.5 Nuovo Biologics Recent Developments
5.19 UBI
5.19.1 UBI Profile
5.19.2 UBI Main Business
5.19.3 UBI Veterinary Vaccines Products, Services and Solutions
5.19.4 UBI Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.19.5 UBI Recent Developments
5.20 Valneva
5.20.1 Valneva Profile
5.20.2 Valneva Main Business
5.20.3 Valneva Veterinary Vaccines Products, Services and Solutions
5.20.4 Valneva Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.20.5 Valneva Recent Developments
5.21 Vetoquinol
5.21.1 Vetoquinol Profile
5.21.2 Vetoquinol Main Business
5.21.3 Vetoquinol Veterinary Vaccines Products, Services and Solutions
5.21.4 Vetoquinol Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.21.5 Vetoquinol Recent Developments
5.22 Virbac
5.22.1 Virbac Profile
5.22.2 Virbac Main Business
5.22.3 Virbac Veterinary Vaccines Products, Services and Solutions
5.22.4 Virbac Veterinary Vaccines Revenue (US$ Million) & (2018-2023)
5.22.5 Virbac Recent Developments
6 North America
6.1 North America Veterinary Vaccines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Vaccines Market Dynamics
11.1 Veterinary Vaccines Industry Trends
11.2 Veterinary Vaccines Market Drivers
11.3 Veterinary Vaccines Market Challenges
11.4 Veterinary Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Veterinary Vaccines Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Veterinary Vaccines Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Veterinary Vaccines Market Size Share by Region (2018-2023)
    Table 4. Global Veterinary Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Veterinary Vaccines Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Veterinary Vaccines Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Veterinary Vaccines Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Veterinary Vaccines Revenue Market Share by Type (2018-2023)
    Table 9. Global Veterinary Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Veterinary Vaccines Revenue Market Share by Type (2024-2029)
    Table 11. North America Veterinary Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Veterinary Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Veterinary Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Veterinary Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Veterinary Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Veterinary Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Veterinary Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Veterinary Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Veterinary Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Veterinary Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Veterinary Vaccines Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Veterinary Vaccines Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Veterinary Vaccines Revenue Market Share by Application (2018-2023)
    Table 24. Global Veterinary Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Veterinary Vaccines Revenue Market Share by Application (2024-2029)
    Table 26. North America Veterinary Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Veterinary Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Veterinary Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Veterinary Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Veterinary Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Veterinary Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Veterinary Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Veterinary Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Veterinary Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Veterinary Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Veterinary Vaccines Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Veterinary Vaccines Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2022)
    Table 39. Date of Key Players Enter into Veterinary Vaccines Market
    Table 40. Global Veterinary Vaccines Key Players Headquarters and Area Served
    Table 41. Veterinary Vaccines Product Solution and Service
    Table 42. Global Veterinary Vaccines Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Elanco Basic Information List
    Table 45. Elanco Description and Business Overview
    Table 46. Elanco Veterinary Vaccines Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Veterinary Vaccines Business of Elanco (2018-2023)
    Table 48. Elanco Recent Developments
    Table 49. Merck Basic Information List
    Table 50. Merck Description and Business Overview
    Table 51. Merck Veterinary Vaccines Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Veterinary Vaccines Business of Merck (2018-2023)
    Table 53. Merck Recent Developments
    Table 54. Merial Basic Information List
    Table 55. Merial Description and Business Overview
    Table 56. Merial Veterinary Vaccines Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Veterinary Vaccines Business of Merial (2018-2023)
    Table 58. Merial Recent Developments
    Table 59. Zoetis Basic Information List
    Table 60. Zoetis Description and Business Overview
    Table 61. Zoetis Veterinary Vaccines Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Veterinary Vaccines Business of Zoetis (2018-2023)
    Table 63. Zoetis Recent Developments
    Table 64. Advaxis Basic Information List
    Table 65. Advaxis Description and Business Overview
    Table 66. Advaxis Veterinary Vaccines Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Veterinary Vaccines Business of Advaxis (2018-2023)
    Table 68. Advaxis Recent Developments
    Table 69. AmpliPhi Biosciences Basic Information List
    Table 70. AmpliPhi Biosciences Description and Business Overview
    Table 71. AmpliPhi Biosciences Veterinary Vaccines Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Veterinary Vaccines Business of AmpliPhi Biosciences (2018-2023)
    Table 73. AmpliPhi Biosciences Recent Developments
    Table 74. Aratana Therapeutics Basic Information List
    Table 75. Aratana Therapeutics Description and Business Overview
    Table 76. Aratana Therapeutics Veterinary Vaccines Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Veterinary Vaccines Business of Aratana Therapeutics (2018-2023)
    Table 78. Aratana Therapeutics Recent Developments
    Table 79. ARKO Labs Basic Information List
    Table 80. ARKO Labs Description and Business Overview
    Table 81. ARKO Labs Veterinary Vaccines Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Veterinary Vaccines Business of ARKO Labs (2018-2023)
    Table 83. ARKO Labs Recent Developments
    Table 84. Bayer Basic Information List
    Table 85. Bayer Description and Business Overview
    Table 86. Bayer Veterinary Vaccines Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Veterinary Vaccines Business of Bayer (2018-2023)
    Table 88. Bayer Recent Developments
    Table 89. CanFel Therapeutics Basic Information List
    Table 90. CanFel Therapeutics Description and Business Overview
    Table 91. CanFel Therapeutics Veterinary Vaccines Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Veterinary Vaccines Business of CanFel Therapeutics (2018-2023)
    Table 93. CanFel Therapeutics Recent Developments
    Table 94. Ceva Animal Health Basic Information List
    Table 95. Ceva Animal Health Description and Business Overview
    Table 96. Ceva Animal Health Veterinary Vaccines Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Veterinary Vaccines Business of Ceva Animal Health (2018-2023)
    Table 98. Ceva Animal Health Recent Developments
    Table 99. Colorado Serum Basic Information List
    Table 100. Colorado Serum Description and Business Overview
    Table 101. Colorado Serum Veterinary Vaccines Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Veterinary Vaccines Business of Colorado Serum (2018-2023)
    Table 103. Colorado Serum Recent Developments
    Table 104. Epitopix Basic Information List
    Table 105. Epitopix Description and Business Overview
    Table 106. Epitopix Veterinary Vaccines Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Veterinary Vaccines Business of Epitopix (2018-2023)
    Table 108. Epitopix Recent Developments
    Table 109. Genus Basic Information List
    Table 110. Genus Description and Business Overview
    Table 111. Genus Veterinary Vaccines Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Veterinary Vaccines Business of Genus (2018-2023)
    Table 113. Genus Recent Developments
    Table 114. Hygieia Biological Laboratories Basic Information List
    Table 115. Hygieia Biological Laboratories Description and Business Overview
    Table 116. Hygieia Biological Laboratories Veterinary Vaccines Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Veterinary Vaccines Business of Hygieia Biological Laboratories (2018-2023)
    Table 118. Hygieia Biological Laboratories Recent Developments
    Table 119. ImmuCell Basic Information List
    Table 120. ImmuCell Description and Business Overview
    Table 121. ImmuCell Veterinary Vaccines Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Veterinary Vaccines Business of ImmuCell (2018-2023)
    Table 123. ImmuCell Recent Developments
    Table 124. Nexvet Basic Information List
    Table 125. Nexvet Description and Business Overview
    Table 126. Nexvet Veterinary Vaccines Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Veterinary Vaccines Business of Nexvet (2018-2023)
    Table 128. Nexvet Recent Developments
    Table 129. Nuovo Biologics Basic Information List
    Table 130. Nuovo Biologics Description and Business Overview
    Table 131. Nuovo Biologics Veterinary Vaccines Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Veterinary Vaccines Business of Nuovo Biologics (2018-2023)
    Table 133. Nuovo Biologics Recent Developments
    Table 134. UBI Basic Information List
    Table 135. UBI Description and Business Overview
    Table 136. UBI Veterinary Vaccines Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Veterinary Vaccines Business of UBI (2018-2023)
    Table 138. UBI Recent Developments
    Table 139. Valneva Basic Information List
    Table 140. Valneva Description and Business Overview
    Table 141. Valneva Veterinary Vaccines Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Veterinary Vaccines Business of Valneva (2018-2023)
    Table 143. Valneva Recent Developments
    Table 144. Vetoquinol Basic Information List
    Table 145. Vetoquinol Description and Business Overview
    Table 146. Vetoquinol Veterinary Vaccines Products, Services and Solutions
    Table 147. Revenue (US$ Million) in Veterinary Vaccines Business of Vetoquinol (2018-2023)
    Table 148. Vetoquinol Recent Developments
    Table 149. Virbac Basic Information List
    Table 150. Virbac Description and Business Overview
    Table 151. Virbac Veterinary Vaccines Products, Services and Solutions
    Table 152. Revenue (US$ Million) in Veterinary Vaccines Business of Virbac (2018-2023)
    Table 153. Virbac Recent Developments
    Table 154. North America Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 155. North America Veterinary Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 156. Europe Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 157. Europe Veterinary Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 158. Asia-Pacific Veterinary Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 159. Asia-Pacific Veterinary Vaccines Market Size by Region (2018-2023) & (US$ Million)
    Table 160. Asia-Pacific Veterinary Vaccines Market Size by Region (2024-2029) & (US$ Million)
    Table 161. Asia-Pacific Veterinary Vaccines Market Share by Region (2018-2023)
    Table 162. Asia-Pacific Veterinary Vaccines Market Share by Region (2024-2029)
    Table 163. Latin America Veterinary Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 164. Latin America Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 165. Latin America Veterinary Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 166. Middle East & Africa Veterinary Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 167. Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 168. Middle East & Africa Veterinary Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 169. Veterinary Vaccines Market Trends
    Table 170. Veterinary Vaccines Market Drivers
    Table 171. Veterinary Vaccines Market Challenges
    Table 172. Veterinary Vaccines Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Veterinary Vaccines Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Veterinary Vaccines Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Veterinary Vaccines Market Share by Regions: 2022 VS 2029
    Figure 4. Global Veterinary Vaccines Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Veterinary Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Veterinary Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Veterinary Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Veterinary Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Veterinary Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Inactivated Vaccines
    Figure 11. Global Inactivated Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Live Attenuated Vaccines
    Figure 13. Global Live Attenuated Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Conjugate Vaccines
    Figure 15. Global Conjugate Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Toxoid Vaccines
    Figure 17. Global Toxoid Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of Recombinant Vaccines
    Figure 19. Global Recombinant Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Product Picture of DNA Vaccines
    Figure 21. Global DNA Vaccines Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Product Picture of Others
    Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Global Veterinary Vaccines Market Size Share by Type: 2022 & 2029
    Figure 25. North America Veterinary Vaccines Revenue Market Share by Type (2018-2029)
    Figure 26. Europe Veterinary Vaccines Revenue Market Share by Type (2018-2029)
    Figure 27. Asia-Pacific Veterinary Vaccines Revenue Market Share by Type (2018-2029)
    Figure 28. Latin America Veterinary Vaccines Revenue Market Share by Type (2018-2029)
    Figure 29. Middle East and Africa Veterinary Vaccines Revenue Market Share by Type (2018-2029)
    Figure 30. Veterinary Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 31. Veterinary Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 32. Veterinary Research Institute Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 33. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 34. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 35. Global Veterinary Vaccines Market Size Share by Application: 2022 & 2029
    Figure 36. North America Veterinary Vaccines Revenue Market Share by Application (2018-2029)
    Figure 37. Europe Veterinary Vaccines Revenue Market Share by Application (2018-2029)
    Figure 38. Asia-Pacific Veterinary Vaccines Revenue Market Share by Application (2018-2029)
    Figure 39. Latin America Veterinary Vaccines Revenue Market Share by Application (2018-2029)
    Figure 40. Middle East and Africa Veterinary Vaccines Revenue Market Share by Application (2018-2029)
    Figure 41. Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 42. Global Top 5 and Top 10 Players Veterinary Vaccines Market Share in 2022
    Figure 43. North America Veterinary Vaccines Market Share by Country (2018-2029)
    Figure 44. U.S. Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 45. Canada Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 46. Germany Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 47. France Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 48. U.K. Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 49. Italy Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 50. Russia Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 51. Nordic Countries Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 52. Asia-Pacific Veterinary Vaccines Market Share by Region (2018-2029)
    Figure 53. China Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 54. Japan Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 55. South Korea Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 56. Southeast Asia Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 57. India Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 58. Australia Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 59. Latin America Veterinary Vaccines Market Share by Country (2018-2029)
    Figure 60. Mexico Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 61. Brazil Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 62. Middle East & Africa Veterinary Vaccines Market Share by Country (2018-2029)
    Figure 63. Turkey Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 64. Saudi Arabia Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 65. UAE Veterinary Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 66. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS